Quarterly report pursuant to Section 13 or 15(d)

Interim Statements of Operations and Comprehensive loss

v2.4.0.6
Interim Statements of Operations and Comprehensive loss (USD $)
3 Months Ended 96 Months Ended
Feb. 28, 2013
Feb. 29, 2012
Feb. 28, 2013
EXPENSES:      
Research and Product Development cost (recovery) $ 0 $ (215,143) $ 7,473,781
Amortization 8,214 2,284 69,158
General and administration 424,999 421,189 12,231,236
TOTAL OPERATING EXPENSES 433,213 208,330 19,774,175
LOSS FROM OPERATIONS (433,213) (208,330) (19,774,175)
Other Expense-Interest (36,435) (44,101) (264,213)
Other Income-Interest 0 0 272,594
LOSS BEFORE INCOME TAXES (469,648) (252,431) (19,765,794)
Income taxes 0 0 0
NET LOSS AND COMPREHENSIVE LOSS $ (469,648) $ (252,431) $ (19,765,794)
Loss per share - basic and diluted $ (0.01) $ (0.01)   
Weighted average common shares outstanding 32,353,157 26,828,050